2016
DOI: 10.18632/oncotarget.10520
|View full text |Cite
|
Sign up to set email alerts
|

Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer

Abstract: Prostate cancer (PCa) is the second most common solid tumor for cancer related deaths in American men. Genome wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with the increased risk of PCa. Because most of the susceptibility SNPs are located in noncoding regions, little is known about their functional mechanisms. We hypothesize that functional SNPs reside in cell type-specific regulatory elements that mediate the binding of critical transcription factors (TFs),… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
32
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(35 citation statements)
references
References 51 publications
2
32
0
1
Order By: Relevance
“…All of the genes with coding variants identified through the GWAS/post-GWAS approach have been included in our pathway analysis. The prominent consequence of non-coding functional variants included in this study [27,28] is mainly due to: i) change in TF binding site pattern [28,29], ii) change in DNA methylation marks [30] and iii) Chromatin architecture alteration [31], or a combination of these mechanisms.…”
Section: Materials and Methods: Prostate Cancer Risk Associated Functmentioning
confidence: 99%
“…All of the genes with coding variants identified through the GWAS/post-GWAS approach have been included in our pathway analysis. The prominent consequence of non-coding functional variants included in this study [27,28] is mainly due to: i) change in TF binding site pattern [28,29], ii) change in DNA methylation marks [30] and iii) Chromatin architecture alteration [31], or a combination of these mechanisms.…”
Section: Materials and Methods: Prostate Cancer Risk Associated Functmentioning
confidence: 99%
“…For example, while we identified 13 local-eQTLs linked to ntc in the infected condition, we are at this point unable to characterize their precise mode of action, preventing insights into the underlying regulatory mechanisms. To validate the effect of a particular variant on relevant genes, eQTL studies have so far often resorted to classical molecular biology techniques such as chromatin immunoprecipitation and small-scale reporter assays [58,59]. While the recent emergence of Massively Parallel Reporter Assays allows for a much more systematic analysis of the regulatory effect of variants in transcriptional elements [60][61][62], these assays are still unable to consider the complex interaction between genetic variation and gene expression.…”
Section: Large-scale In Vivo Local-eqtl Characterization Via Allelespmentioning
confidence: 99%
“…В Японии полиморфизм rs62285902 гена NAALADL2 найден как маркер болезни Крона по данным полногеномного ассоциативного исследования [12]. Обнаружено, что гиперэкспрессия гена NAALADL2 при раке толстой кишки и простаты играет значимую роль в развитии и прогрессировании онкологического процесса [13]. Полиморфизм rs78943174 выявлен как ассоциированный с агрессивностью рака простаты, учитывавшийся по шкале Глисона [14].…”
Section: однонуклеотидныйunclassified